Imaging of the dopaminergic system in parkinsonism with SPET
Author:
- 1 July 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 22 (7) , 819-827
Abstract
Parkinsonism is a feature of various neurodegenerative diseases. Since it is well known that the dopaminergic system plays a major role in parkinsonism, numerous reports have focused on the assessment of the dopaminergic system in vivo. While the use of positron emission tomography (PET) for routine application is still hampered by its limited availability, single photon emission tomography (SPET) has been shown to deliver comparable results to PET in clinical settings. In recent years SPET investigations of the dopamine transporter and of the dopamine D2-like receptors have provided valuable information about the pre- and postsynaptic dopaminergic system in parkinsonism. This article briefly reviews the literature dealing with SPET imaging in parkinsonism and specifically addresses the ligands used, the methodology applied, and the current major clinical applications.Keywords
This publication has 51 references indexed in Scilit:
- Automatic segmentation of dynamic neuroreceptor single-photon emission tomography images using fuzzy clusteringEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)Nuclear Medicine and Biology, 1998
- Advances in imaging Parkinsonʼs diseaseCurrent Opinion in Neurology, 1997
- Single Photon Emission Computed Tomography Imaging of Dopaminergic Function: Presynaptic Transporter, Postsynaptic Receptor, and “Intrasynaptic” Transmitter1997
- IPT: A novel iodinated ligand for the CNS dopamine transporterSynapse, 1995
- N-.omega.-Fluoroalkyl Analogs of (1R)-2.beta.-Carbomethoxy-3.beta.-(4-iodophenyl)tropane (.beta.-CIT): Radiotracers for Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging of Dopamine TransportersJournal of Medicinal Chemistry, 1994
- Preparation of 123I-labeled 2′-iodospiperone and imaging of D2 dopamine receptors in the human brain using SPECTInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- [123I]-2.beta.-carbomethoxy-3.beta.-(4-iodophenyl)tropane: high-affinity SPECT (single photon emission computed tomography) radiotracer of monoamine reuptake sites in brainJournal of Medicinal Chemistry, 1991
- High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptorsLife Sciences, 1991